April 10, 2018
Biomax Informatics AG announces that their longtime client, Boehringer Ingelheim, has signed a multi-year license for the BioXM™ Knowledge Management Environment to support their global target discovery research. In addition, the company has extended their license for Biomax’s BioRS™ Integration and Retrieval System. Boehringer Ingelheim is using the BioXM™ Knowledge Management Environment to build and [...]
Early Discovery Chemistry Workflow Benefits from Parallel Synthesiser
April 9, 2018
Asynt reports on how a DrySyn OCTO 8-position parallel synthesiser has benefited early stage discovery chemistry at Cancer Research UK (Cambridge, UK). Designed to work with any hotplate stirrer, the DrySyn Octo has enabled the CRUK Therapeutic Discovery Laboratories to increase the productivity of their small-scale synthetic reactions. Dr Peter Blencowe, a senior scientist at [...]
Agilent Highlights Lab Efficiency Through Innovative Solutions at Analytica 2018
April 9, 2018
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE: A) today announced that it will showcase its line-up of innovative solutions for laboratory efficiency at Analytica, being held April 10 – 13, in Munich, Germany. This year at the 26th international trade fair for laboratory technology, analysis, and biotechnology, Agilent brings lab efficiency solutions to the forefront with a [...]
April 9, 2018
Jena – From now on, two high-performance technologies from Analytik Jena go hand in hand: Mass spectrometry with inductively coupled plasma (ICP-MS) and high-performance liquid chromatography (HPLC). At analytica 2018 in Munich, the Thuringia-based company is presenting a new HPLC module for its very successful PlasmaQuant® MS mass spectrometer series. By doing so, Analytik Jena has [...]
April 9, 2018
Munich, Germany: GNA Biosolutions GmbH will be showcasing the Pharos V8, the world’s first Laser PCR instrument based on the company’s proprietary Pulse Controlled Amplification (PCA) technology at the Analytica trade fair (Booth A3/522) in Munich, Germany from April 10-13. Launched in November 2017, the Pharos V8 delivers ultrafast PCR results in 10 minutes or [...]
OGT announces organisational changes
April 9, 2018
Appointments strengthen push into molecular diagnostics Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that on 1st April 2018 Dr John Anson who has been with the company since 2006 as EVP of R&D took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT’s board. [...]
April 9, 2018
Earlham Institute (EI) add Illumina’s NovaSeq 6000 to its National Capability in Genomics and Single Cell Analysis, harnessing the power of ultra-high throughput sequencing for Norwich Research Park and the wider bioscience community. The new platform will increase its sequencing capacity threefold and enable big data science more rapidly and cost-effectively than ever before, with [...]
MILabs’ preclinical imaging annual sales grows again by nearly 50%
April 6, 2018
UTRECHT, THE NETHERLANDS MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continued on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close to 50%. “The dramatic increase in sales validates the design and functionality of our multimodal imaging platform and confirms that it enables [...]
April 6, 2018
ST. LOUIS--PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that TriCore Reference Laboratories will utilize the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for genomic analytics, classification, interpretation and reporting. TriCore will join more than 50 other customers who benefit from shared interpretations in the PierianDx KnowledgeSpace, a [...]
Genovis signs distribution agreement for South Korean market
April 6, 2018
Genovis continues to expand in Asia and has signed a distribution agreement with Chayon Laboratories Inc. for the South Korean market. The agreement covers sales from Genovis’ current and future products. It was a South Korean company that had the world’s first antibody-biosimilar approved. Since then, the market for biopharmaceuticals has continued to grow strongly [...]
